Effect of life quality and survival rate of palliative surgery combined with FOLFOX adjuvant chemotherapy on treatment of advanced rectal cancer in elderly patients
10.3969/j.issn.1005-1678.2017.10.107
- VernacularTitle:姑息手术联合FOLFOX辅助化疗对老年中晚期直肠癌患者生存率及生活质量的影响
- Author:
ting Shi JIA
1
;
Feng YING
Author Information
1. 永康市第一人民医院 肛肠外科
- Keywords:
palliative surgery;
FOLFOX adjuvant chemotherapy;
elderly patients with advanced rectal cancer;
survival rate;
quality of life
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(10):248-249
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the survival rate and effects of life quality of palliative surgery combined with FOLFOX adjuvant chemotherapy on advanced rectal cancer treatment in elderly patients. Methods 100 elderly patients with advanced rectal cancer from May 2015 to May 2017, were randomly divided into the control group and the experimental group, 50 patients for each group. The control group was treated with palliative surgery. Patients in the experimental group were given palliative surgery and FOLFOX adjuvant chemotherapy. The survival rate and quality of life score were compared between the experimental and control groups. Results One year survival rate was 76% in the experimental group. One year survival rate was 52% in the control group. The survival rate of the experimental group was significantly higher than that of the control group, with statistical difference (P<0.05). After treatment, the total score of quality of life in the experimental group was (75.2 ± 11.2) points, and the total score of QOL in the control group was (64.2±9.3) points. The quality of life score of the control group was lower than that of the experimental group, with statistical difference (P<0.05). Conclusion Palliative surgery combined with FOLFOX adjuvant chemotherapy could significantly improve the survival rate of elderly patients with advanced rectal cancer and the quality of life.
